Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression
Part of paid clinical trials in San Diego, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT07834762
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Major Depressive Disorder (MDD)
- Treatment Resistant Depression (TRD)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Spaced Transcranial Direct Current Stimulation (tDCS) — DEVICESpaced-tDCS will be self-administered at home under the supervision of a trained clinical research coordinator using the Soterix Medical mini-CT device with remote monitoring via a secure videoconferencing platform (e.g., Microsoft Teams).
- Sham Spaced tDCS — DEVICESoterix Medical mini-CT device sham protocol that match real stimulation parameters will be used.
Study Details
This study aims to evaluate the clinical efficacy and neurophysiological mechanisms of home-based spaced tDCS in TRD through a randomized, double-blind, sham-controlled trial conducted under remote supervision. Specifically, this trial will: (1) compare the efficacy of active versus sham spaced tDCS on depressive symptom severity in individuals with TRD and (2) characterize neurophysiological changes associated with spaced tDCS using TMS-EEG, TMS-EMG and resting state EEG.
Key Dates
- First listed
- Sep 22, 2026
- Start date
- Oct 15, 2026
- Status verified
- Sep 2026
- Primary completion
- Oct 15, 2031
- Completion
- Oct 15, 2031
Study Design
- Enrollment
- 74 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active spaced-tDCSActive tDCS applies low-intensity electrical current to the scalp to modulate cortical excitability through subthreshold shifts in neuronal membrane potentials, influencing synaptic plasticity
- Sham Comparator: Sham spaced-tDCSSham tDCS is a placebo control that simulates the physical sensations of tDCS but does not deliver any actual, prolonged electrical current to the brain.
Primary Outcome Measure
Active vs Sham spaced tDCS Efficacy as measured by the Montgomery-Åsberg Depression Rating Scale [ Time Frame: Baseline to 4-weeks post treatment ]
Central Contacts
- Interventional Psychiatry858-657-6149
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCSD Interventional Psychiatry | San Diego | California | 92127 | UCSD Interventional Psychiatry Clinic 858-207-0938 |
Find similar trials in San Diego, CA
Related Studies
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPHASE3 · Recruiting · Cybin IRL Limited · Birmingham, Alabama
- Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPHASE3 · Recruiting · Vanda Pharmaceuticals · Phoenix, Arizona
- Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide RiskRecruiting · University of California, Davis · Sacramento, California
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)PHASE2 · Recruiting · Seaport Therapeutics · Chino, California